Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR2 | P21802 | 2/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15256185 | 0.96 | L3MBTL1 (0.43) | FGFR2FGFR1PTPRCKDM4ENPC1 | |
| SCHEMBL21609908 | 0.95 | ADORA1 (0.44) | FGFR2FGFR1PTPRCKDM4ENPC1 | |
| SCHEMBL21609904 | 0.89 | FGFR2 (0.44) | FGFR2FGFR1PTPRCKDM4ENPC1 | |
| SCHEMBL9563850 | 0.86 | NQO1 (0.48) | FGFR2FGFR1KDM4ENPC1RAB9A | |
| SCHEMBL9492786 | 0.86 | NQO1 (0.48) | FGFR2FGFR1KDM4ENPC1RAB9A | |
| SCHEMBL16771252 | 0.86 | ADORA3 (0.42) | FGFR2FGFR1PTPRCKDM4ENPC1 | |
| SCHEMBL21609902 | 0.86 | KDM4E (0.43) | FGFR2FGFR1PTPRCKDM4ENPC1 | |
| SCHEMBL9495395 | 0.86 | PTPN11 (0.46) | KDM4EL3MBTL1ADRB2ALOX5APFEN1 | |
| SCHEMBL8932603 | 0.86 | TAAR1 (0.45) | FGFR2FGFR1KDM4EHSD17B10L3MBTL1 | |
| SCHEMBL15381834 | 0.85 | FGFR2 (0.39) | FGFR2FGFR1PTPRCKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303928-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND LIQUID CRYSTAL DISPLAY | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO.,LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| US-20230183572-A1 | LIQUID CRYSTAL COMPOSITION WITH GOOD FREQUENCY DEPENDENCE AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183573-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230167362-A1 | NEGATIVE LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT OR LIQUID CRYSTAL DISPLAY | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MAT CO ITD (CN) | 2023-06-01 | — | — | US | disclosed |
| US-11208395-B2 | Compound, liquid crystal medium containing the compound and application thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2021-12-28 | — | — | US | disclosed |
| US-11155752-B2 | Liquid crystal composition and display device thereof | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-10-26 | — | — | US | disclosed |
| US-20210017450-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE HAVING SAME | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-01-21 | — | — | US | disclosed |
| US-10519377-B1 | Liquid crystal composition of negative monomer containing cyclopentyl cyclohexenyl and liquid crystal display element or liquid crystal display thereof | Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd (CN) | 2019-12-31 | — | — | US | disclosed |
| US-20190345129-A1 | COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING THE COMPOUND AND APPLICATION THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-11-14 | — | — | US | disclosed |
| US-20190345386-A1 | LIQUID CRYSTAL COMPOSITION AND DISPLAY DEVICE THEREOF | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2019-11-14 | — | — | US | disclosed |
| US-10351773-B2 | Liquid crystal compounds of cycloalkyl-containing dibenzofuran derivatives, preparation method therefor and use thereof | Shijiazhuang Chengzhi Yonghua Display Material Co., Ltd (CN) | 2019-07-16 | — | — | US | disclosed |
| US-20180112132-A1 | LIQUID CRYSTAL COMPOUNDS OF CYCLOALKYL-CONTAINING DIBENZOFURAN DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO.,LTD (CN) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180112132-A1 | LIQUID CRYSTAL COMPOUNDS OF CYCLOALKYL-CONTAINING DIBENZOFURAN DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | CYP4F11, WASF2, NOTUM | FGFR2 596/4885FGFR1 454/4885PTPRC 4682/4885 |
| US-20190345129-A1 | COMPOUND, LIQUID CRYSTAL MEDIUM CONTAINING THE COMPOUND AND APPLICATION THEREOF | ABCG2, TPST2, TST | FGFR2 78/4885FGFR1 128/4885PTPRC 2476/4885 |
| US-11208395-B2 | Compound, liquid crystal medium containing the compound and application thereof | TST, TPST2, ABCG2 | FGFR2 70/4885FGFR1 134/4885PTPRC 2311/4885 |
| US-10351773-B2 | Liquid crystal compounds of cycloalkyl-containing dibenzofuran derivatives, preparation method therefor and use thereof | CYP4F11, WASF2, NOTUM | FGFR2 596/4885FGFR1 454/4885PTPRC 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.